252 related articles for article (PubMed ID: 21285393)
1. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
Mendoza TR; Wang XS; Lu C; Palos GR; Liao Z; Mobley GM; Kapoor S; Cleeland CS
Oncologist; 2011; 16(2):217-27. PubMed ID: 21285393
[TBL] [Abstract][Full Text] [Related]
2. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
[TBL] [Abstract][Full Text] [Related]
3. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
[TBL] [Abstract][Full Text] [Related]
4. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
[TBL] [Abstract][Full Text] [Related]
5. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
[TBL] [Abstract][Full Text] [Related]
6. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language.
Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A
J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822
[TBL] [Abstract][Full Text] [Related]
7. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
[TBL] [Abstract][Full Text] [Related]
8. A Psychometric Evaluation of the Chinese Version of the M.D. Anderson Symptom Inventory-Heart Failure in Chinese Cancer Patients With Concurrent Heart Failure.
Chair SY; Wang Q; Yu M; Kwok Wei So W; Tian C; Wing Hung Sit J; Mi Ling Wong E; Wing Han Chan C; Fadol A
Rehabil Nurs; 2017; 42(6):354-361. PubMed ID: 29244037
[TBL] [Abstract][Full Text] [Related]
9. Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory Gastrointestinal Cancer Module (MDASI-GI-C).
Chen RW; Yang SL; Xu ZY; Peng M; Chen MN; Wang QS; Chang J; Hu JL
J Pain Symptom Manage; 2019 Apr; 57(4):820-827. PubMed ID: 30684634
[TBL] [Abstract][Full Text] [Related]
10. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.
Sailors MH; Bodurka DC; Gning I; Ramondetta LM; Williams LA; Mendoza TR; Agarwal S; Sun CC; Cleeland CS
Gynecol Oncol; 2013 Aug; 130(2):323-8. PubMed ID: 23685012
[TBL] [Abstract][Full Text] [Related]
11. Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory.
Gning I; Trask PC; Mendoza TR; Harle MT; Gutierrez KA; Kitaka SA; Sherman SI; Cleeland CS
Oncology; 2009; 76(1):59-68. PubMed ID: 19052478
[TBL] [Abstract][Full Text] [Related]
12. Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module.
Tanaka S; Sato I; Takahashi M; Armstrong TS; Cleeland CS; Mendoza TR; Mukasa A; Takayanagi S; Narita Y; Kamibeppu K; Saito N
Jpn J Clin Oncol; 2020 Jul; 50(7):787-793. PubMed ID: 32280995
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Amharic Version of the M. D. Anderson Symptom Inventory and Assessment of Symptoms in Ethiopian Cancer Patients.
Anshabo AT; Migbaru S; Mulu A; Negusu D; Asfaw AA; Awoke D; Tigeneh W; Engidawork E
J Pain Symptom Manage; 2016 May; 51(5):947-53. PubMed ID: 26988847
[TBL] [Abstract][Full Text] [Related]
14. Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer.
Williams LA; Agarwal S; Bodurka DC; Saleeba AK; Sun CC; Cleeland CS
J Pain Symptom Manage; 2013 Dec; 46(6):837-45. PubMed ID: 23615044
[TBL] [Abstract][Full Text] [Related]
15. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group.
Jones D; Zhao F; Fisch MJ; Wagner LI; Patrick-Miller LJ; Cleeland CS; Mendoza TR
Clin Genitourin Cancer; 2014 Feb; 12(1):41-9. PubMed ID: 24126238
[TBL] [Abstract][Full Text] [Related]
16. Measuring the symptom burden associated with the treatment of chronic myeloid leukemia.
Williams LA; Garcia Gonzalez AG; Ault P; Mendoza TR; Sailors ML; Williams JL; Huang F; Nazha A; Kantarjian HM; Cleeland CS; Cortes JE
Blood; 2013 Aug; 122(5):641-7. PubMed ID: 23777764
[TBL] [Abstract][Full Text] [Related]
17. Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting.
Kamal M; Navai N; Bree KK; Williams LA; Cleeland CS; Shen SE; Wang XS
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010890
[TBL] [Abstract][Full Text] [Related]
18. Development of a patient-reported outcome tool for assessing symptom burden during perioperative care in liver surgery: The MDASI-PeriOp-Hep.
Wang XS; Shi Q; Williams LA; Lillemoe HA; Chen TY; Gottumukkala V; Garcia-Gonzalez A; Malveaux D; Kamal M; Cleeland CS; Aloia TA
Eur J Oncol Nurs; 2021 Jun; 52():101959. PubMed ID: 33964632
[TBL] [Abstract][Full Text] [Related]
19. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT).
Armstrong TS; Mendoza T; Gning I; Coco C; Cohen MZ; Eriksen L; Hsu MA; Gilbert MR; Cleeland C
J Neurooncol; 2006 Oct; 80(1):27-35. PubMed ID: 16598415
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
Mendoza TR; Williams LA; Keating KN; Siegel J; Elbi C; Nowak AK; Hassan R; Cuffel B; Cleeland CS
J Patient Rep Outcomes; 2019 Jun; 3(1):34. PubMed ID: 31209661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]